Resolution: standard / high
Figure 3.
Cost-effectiveness acceptability curve for pioglitazone versus placebo.
Scherbaum et al. Cost Effectiveness and Resource Allocation 2009 7:9 doi:10.1186/1478-7547-7-9
Download authors' original image